An Open Label Study to Investigate the Relative Bioavailability, Food Effect and Effect of Ketoconazole on the Rate and Extent of Absorption of Solid Dosage Formulation(s) of JNJ-40411813
Latest Information Update: 12 Sep 2013
At a glance
- Drugs ADX 71149 (Primary) ; Ketoconazole
- Indications Major depressive disorder; Psychiatric disorders; Schizophrenia
- Focus Pharmacokinetics
- 03 Sep 2013 New trial record